Hakim-Moulay Dehbi

9PUBLICATIONS
55CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursExercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 30, 2026
Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

|Apr 01, 2026
Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled Trial.

James Lyon, Philip S Nash, Norin Ahmed

|Dec 18, 2025
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

Moritz J Hundertmark, Sarah M Birkhoelzer, Clara Portwood

|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial.

Philip S Nash, Hakim-Moulay Dehbi, Norin Ahmed

|May 19, 2025
Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-Inferiority.

Hakim-Moulay Dehbi, Sean Devlins, Alexia Iasonos

|Apr 15, 2024
The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies.

Cody Chiuzan, Hakim-Moulay Dehbi

Pageof 2

Frequent Collaborators

2 joint publications

Ekaterina Bordea

2 joint publications

Bo Norrving

2 joint publications

Robert Fenner

2 joint publications

Hannah Cohen